Équipe Vision

Mise à jour le   14/04/2026

The VISION team at LaTIM (Visual System Information: Instrumentation and Analysis), led by Prof. Béatrice Cochener, focuses its research on the human visual system in both health and disease, combining instrumental and computational approaches. The team relies on complementary expertise in optics, image processing, machine learning, and explainable artificial intelligence.

This axis focuses on the design of advanced algorithms for:

  • Automated analysis of 2D and 3D ophthalmic images (fundus photographs, OCT, OCT-A, surgical videos, etc.);
  • Image-guided surgery, particularly in ophthalmology;
  • Detection of systemic diseases visible through the eye, including diabetes, cardiovascular diseases, and neurodegenerative disorders;
  • Integration of visual and vocal signals in mental health projects, such as suicide prevention, analysis of social interactions in autism, and neurological studies including Parkinson’s disease stratification;
  • Exploitation of multimodal and longitudinal data within a predictive medicine framework.

Contact

Gwenolé Quellec

This axis develops novel optical technologies and embedded sensors to:

  • Enhance natural vision (e.g., intraocular implants for presbyopia correction);
  • Rehabilitate impaired vision (e.g., instrumented lenses and eye-tracking devices robust to real-world environments);
  • Study and model visual perception under natural conditions.

The team collaborates actively with other LaTIM teams, partner hospitals, and a national and international academic and industrial network. It also ensures technology transfer of its solutions toward industrial partners through:

  • Development of integrable software and technological prototypes;
  • Collaborative programs such as LabCom partnerships, CIFRE PhDs, PEPR Digital Health initiatives, and RHU/ANR consortia;
  • Technology transfer and co-development activities targeting socio-economic stakeholders.
     

Contact

Vincent Nourrit

Quelques Projets

  • RHU-EVIRED (Intelligent Evaluation of Diabetic Retinopathy)
  • RaReTIA (Rare eye disease characterization using AI and multi-modal fusion)
  • TEDIA (Exchange and Development Therapy for Autism Assisted by Artificial Intelligence)
  • EvoluPark (Multimodal Foundation Models for Diagnosis and Multi-Scale Characterization of Parkinson’s Disease Progression)
     

team leader

Pr. Béatrice COCHENER-LAMARD

Permanent members

Dr. Sofian BERROUIGUET

Dr. Mostafa EL HABIB DAHO

Dr. Mathieu LAMARD

Dr. Laura MACHART

Dr. Sarah MATTA

Dr. Tinashe MUTSVANGWA

Pr. Vincent NOURRIT

Dr. Gwenolé QUELLEC

Contacts